Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2026-02-04 @ 1:30 AM
Study NCT ID:
NCT00521859
Status:
COMPLETED
Last Update Posted:
2012-07-31
First Post:
2007-08-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2005-0844
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |